BioSpace News Archive

BioForest

Juno To Present At March 2017 Investor Conferences

March 1, 2017
·
4 min read
Business

Sarepta Announces Fourth Quarter And Full-Year 2016 Financial Results And Recent Corporate Developments

March 1, 2017
·
1 min read
Business

Ligand Expands License With Sermonix To Include Worldwide Rights For Oral Lasofoxifene

March 1, 2017
·
5 min read
Genetown

Alere Informs Abbott of New Asia Accounting Snafu, Delays Filing Annual Report

March 1, 2017
·
1 min read
Pharm Country

Merck & Co. Announces Second-Quarter 2017 Dividend

March 1, 2017
·
2 min read
Drug Development

Sangamo Therapeutics Receives Orphan Drug Designation From The FDA For SB-913 Genome Editing Treatment For MPS II

March 1, 2017
·
4 min read
FDA

Perrigo Announces FDA Final Approval For The Generic Version Of Axiron Topical Solution, 30 mg/1.5 mL

March 1, 2017
·
3 min read
Drug Development

Adynxx Initiates ADYX-004, A Phase II Study Of AYX1, Lead Compound For The Treatment Of Post-Surgical Pain

March 1, 2017
·
4 min read
Drug Development

Audentes Announces Commencement Of LUSTRO, A Clinical Assessment And Phase I/II Run-In Study Of Patients With Crigler-Najjar Syndrome

March 1, 2017
·
5 min read
Drug Development

SELLAS Life Sci Announces Updated Positive Phase II Data Reinforcing Meaningful Clinical Benefit Of Its WT1 Immunotherapeutic Anti-Cancer Treatment In Multiple Myeloma Patients

March 1, 2017
·
5 min read